Toggle navigation
Home
Search
Services
Blog
Contact
About
New Approaches to Cancer Diagnosis and Treatment
Xu, Yong-Hua
C.P.Li Biomedical Research Corporation, Arlington, VA, United States
Search 3 grants from Yong-Hua Xu
Search grants from C.P.Li Biomedical Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Scholars in Oncology Associated Research (SOAR)
Integrated Care Clinics for IDUs in India: a cluster randomized trial
Gene Expression Profiling of Unknown Primary Cancers
Pathophysiology of Ventricular-Vascular Interaction
CAREER: Environmental Engineering Education and Research in Support of Risk-Based Decision-Making
Recently added grants:
Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans
The Family Input for Quality and Safety (FIQS) Study
Organization of the Mammalian Mitotic Spindle
Training Program in Hematopoietic Cell Transplantation
Advanced Molecular Probes and Cell Engineering Tools for Accurate Single-Molecule Analysis of Signaling in Individual Cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA061619-03
Application #
2102356
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1995-01-05
Project End
1996-11-19
Budget Start
1996-01-01
Budget End
1996-11-19
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
C.P.Li Biomedical Research Corporation
Department
Type
DUNS #
City
Arlington
State
VA
Country
United States
Zip Code
22201
Related projects
NIH 1996
R44 CA
New Approaches to Cancer Diagnosis and Treatment
Xu, Yong-Hua / C.P.Li Biomedical Research Corporation
NIH 1995
R44 CA
New Approaches to Cancer Diagnosis and Treatment
Xu, Yong-Hua / C.P.Li Biomedical Research Corporation
Comments
Be the first to comment on Yong-Hua Xu's grant